[ Price : $8.95]
Stakeholders praise an agreement with FDA to extend the Generic Drug User Fee Act program for another five years.[ Price : $8.95]
FDA grants Cynapsus Therapeutics a fast track designation for APL-130277, a product candidate for treating off episodes in patient...[ Price : $8.95]
Researchers list in the New England Journal of Medicine steps researchers can take to try to reduce having a clinical trial primar...[ Price : $8.95]
The HHS Office of Inspector posts a corporate integrity agreement between the government and Minneapolis-based Cardiovascular Syst...[ Price : $8.95]
Three stakeholders ask for clarifications in an FDA draft guidance on drug product elemental impurities.[ Price : $8.95]
An Alabama federal court approves a Sandoz motion to dismiss claims against it alleging improper warnings about the risks of amiod...[ Price : $8.95]
Attorney Bradley Davidsen says a new FDA draft guidance on safety updates to some generic drug labels raises hope that the agency ...[ Price : $8.95]
FDA plans a two-day public hearing in November to obtain input on off-label communication by drug and medical device companies.